In addition, P53 silencing reduced the efficacy of 5FU activity and in this context, the addition of fulvestrant to 5FU did not enhance tumor growth suppression compared to fulvestrant alone (Fig. 1l, m and Supplementary Fig. 1c). The gene discussed is TP53; the disease is neoplasm.